European Journal of Clinical Microbiology & Infectious Diseases

Papers
(The H4-Index of European Journal of Clinical Microbiology & Infectious Diseases is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Iron serum levels and iron homeostasis parameters in patients with nosocomial pneumonia treated with cefiderocol: post hoc analysis of the APEKS-NP study71
Evaluation of metagenomic next-generation sequencing (mNGS) combined with quantitative PCR: cutting-edge methods for rapid diagnosis of non-invasive fungal rhinosinusitis54
Household transmission of SARS-CoV-2 infection in the Paris/Ile-de-France area53
Correction to: Added diagnostic value of 16S rRNA gene pan-mycobacterial PCR for nontuberculous mycobacterial infections: a 10-year retrospective study49
Retrospective and prospective evaluation of the FluoroType®-Mycobacteria VER 1.0 assay for the identification of mycobacteria from cultures in a French center44
Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience43
Adaptation and performance evaluation of the French society of microbiology algorithm for detection of carbapenemase-producing enterobacterales using VITEK2 antibiotic susceptibility testing system38
Fatal necrotizing fasciitis in a dog caused by NDM-producing extensively drug-resistant Acinetobacter baumannii: a case report36
In-vitro activity of the novel β-lactam/β-lactamase inhibitor combinations and cefiderocol against carbapenem-resistant Pseudomonas spp. clinical isolates collected in Switzerland in 202234
Advances in the detection of Drug-Resistant bacteria: current trends and innovations34
Incidence trends and epidemiology of invasive device-associated bacteremia in French nursing home residents, 2020–2024: Insights from the SPIADI Prospective Multicenter Study33
Understanding bacterial diversity, infection dynamics, prevention of antibiotic resistance: an integrated study in an Algerian hospital context30
Antibiotic practices in kidney transplant recipients with urosepsis are associated with treatment outcomes – a post-hoc analysis of an observational study30
Extensively drug-resistant Haemophilus influenzae isolated in Geneva, Switzerland30
Multicenter interlaboratory study of routine systems for the susceptibility testing of temocillin using a challenge panel of multidrug-resistant strains30
Derivation and validation of a predictive mortality model of in-hospital patients with Acinetobacter baumannii nosocomial infection or colonization30
Antimicrobial activities of aztreonam-avibactam and comparator agents tested against Enterobacterales from European hospitals analysed by geographic region and infection type (2019–2020)28
“Catheter replacement in catheter-associated urinary tract infection: current state of evidence “27
Does selective digestive decontamination (SDD) increase antibiotic resistance? Long-term comparison of two intensive care units (with and without SDD) of the same tertiary hospital27
Efficacy analysis of intraventricular/intrathecal polymyxin B sulphate injections in the treatment of Post-neurosurgical CNS infections in neurocritical ill patients: a prospective observational study26
VanA-Enterococcus faecalis in Poland: hospital population clonal structure and vanA mobilome26
Clinical evaluation of the DermatoPlex qPCR assay for the detection of dermatophyte fungi and Candida spp26
COVID-19 evolution in pediatric emergency department patients in Madrid, Spain: a single-center, retrospective study25
Antimicrobial use, healthcare-associated infections, and bacterial resistance in general hospitals in China: the first national pilot point prevalence survey report24
Increasing usage of chlorhexidine in health care settings: blessing or curse? A narrative review of the risk of chlorhexidine resistance and the implications for infection prevention and control24
A previously documented Neisseria macacae isolate providing a false-positive result with Roche cobas 4800 CT/NG does not cross-react with the later generation cobas 6800 CT/NG assay24
Real-world experience with meropenem/vaborbactam for the treatment of infections caused by ESBL-producing Enterobacterales and carbapenem-resistant Klebsiella pneumoniae24
0.22283506393433